A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.

[1]  J. Coll,et al.  The glycoprotein G of rhabdoviruses , 2005, Archives of Virology.

[2]  D. Hankins,et al.  Overview, prevention, and treatment of rabies. , 2004, Mayo Clinic proceedings.

[3]  C. Jallet,et al.  Inactivated rabies vaccine control and release: use of an ELISA method. , 2003, Biologicals : journal of the International Association of Biological Standardization.

[4]  J. Torroba,et al.  Evaluation of standard reagents for radial-immunodiffusion assays. In vitro control of rabies vaccines. , 2000, Revista do Instituto de Medicina Tropical de Sao Paulo.

[5]  P. Perrin,et al.  DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. , 1998, Vaccine.

[6]  T. Hulland.  A Biographical History of Veterinary Pathology , 1997 .

[7]  H. Koprowski,et al.  Laboratory Techniques in Rabies , 2022 .

[8]  A. Heath,et al.  Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. , 1992, Biologicals : journal of the International Association of Biological Standardization.

[9]  P. Perrin,et al.  In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. , 1990, Biologicals : journal of the International Association of Biological Standardization.

[10]  P. Sureau.  Rabies vaccine production in animal cell cultures. , 1987, Advances in biochemical engineering/biotechnology.

[11]  P. Perrin,et al.  Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. , 1985, Journal of biological standardization.

[12]  P. Perrin,et al.  Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies. , 1985, Vaccine.

[13]  H. Koprowski,et al.  Antigenic properties of rabies virus components. , 1973, Journal of immunology.